ClinicalTrials.Veeva

Menu

Sarcopenic Obesity in Neurodisabilities (SarcObeNDS)

D

Dionyssiotis, Yannis, M.D.

Status

Completed

Conditions

Traumatic Brain Injury
Sarcopenic Obesity
Stroke
Spinal Cord Injuries
Multiple Sclerosis

Treatments

Diagnostic Test: whole body DXA

Study type

Observational

Funder types

Other

Identifiers

NCT03863379
AFIAP2019-01

Details and patient eligibility

About

To describe the frequency and thresholds for sarcopenic obesity in neurodisabled persons and the fat and lean mass distribution based on various neurodisabilities

Enrollment

150 patients

Sex

All

Ages

20 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Persons with

  • stroke / cerebrovascular disease
  • traumatic brain injury
  • multiple sclerosis
  • spinal cord injuries (including spinal cord lesions i.e. myelopathies etc.)

Exclusion criteria

Persons with

  • heterotopic ossifications,
  • chronic administration of drugs, which promote fat increase
  • chronic administration of drugs, which promote bone or muscle loss
  • co-existing other diseases such as: endocrinopathies, muscular dystrophies, non-alcoholic fatty liver disease.

Trial design

150 participants in 2 patient groups

Neurodisabled persons
Description:
Persons with various neurodisabilities
Treatment:
Diagnostic Test: whole body DXA
Control group
Description:
Able bodied persons
Treatment:
Diagnostic Test: whole body DXA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems